RecruitingNCT04312854
A Prospective Cohort Study of IRPF in China
Studying IgG4-related retroperitoneal fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking Union Medical College Hospital
- Principal Investigator
- Wen Zhang, MDDepartment of Rheumatology,Peking Union Medical College Hospital
- Enrollment
- 500 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2020 – 2030
Study locations (1)
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04312854 on ClinicalTrials.govOther trials for IgG4-related retroperitoneal fibrosis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT06741423Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via RadiomicsHeidelberg University
- RECRUITINGPHASE4NCT05428826Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal FibrosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT04314323National Registry of IRPF in ChinaPeking Union Medical College Hospital
- RECRUITINGPHASE2, PHASE3NCT04047576Study of Sirolimus in Idiopathic Retroperitoneal FibrosisPeking University International Hospital